Overview

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

Status:
Completed

Trial end date:
2010-06-23

Target enrollment:

Participant gender:

Summary

This is a research study designed to look at the efficacy and safety of daptomycin given at a dose of 6 mg/kg or 8 mg/kg in subjects being treated for prosthetic hip or knee infections caused by Staphylococci. These types of bacteria are among the most common types of bacteria causing infections of prosthetic joints.

Phase:

Phase 2

Details

Lead Sponsor:

Cubist Pharmaceuticals LLC

Treatments:

Daptomycin
Floxacillin
Nafcillin
Oxacillin
Teicoplanin
Vancomycin